2[1]Fatini C,Abbate R,Pepe G,et al.The role of angiotensinconverting enzyme,angiotensin Ⅱ type 1 receptor and angiotensinogen gene polymorphisms[J].Eur Heart J,2000,21(8):633-638.
3[3]Colombo MG,Andreassi MG,Paradossi U,et al.Evidence for association of a common variant of the endothelial nitric oxide synthase gene (Glu298 → Asp polymorphism) to the presence,extent and severity of coronary artery disease[J].Heart,2002,87(6):525-528.
4[4]Colombo MG,Paradossi U,Andreassi MG,et al.Endothe lial nitric oxide synthase gene polymorphisms and risk of coronary artery disease[J].Clin Chem,2003,49(3):389 395.
6[6]Rao S,Austin H,Davidoff MN,et al.Endothelial nitric oxide synthase intron 4 polymorphism is a marker for coronary artery disease in African-American and Caucasian men[J].Ethn Dis,2005,15(2):191-197.
7[7]Matyar S,Attila G,Acarturk E,et al.eNOS gene intron 4a/ b VNTR polymorphism is a risk factor for coronary artery disease in Southern Turkey[J].Clin Chim Acta,2005,354(1-2):153-158.
8[8]Liu PY,Chen JH,Li YH,et al.Synergistic effect of stromelysin-1 (matrix metallo-proteinase-3) promoter 5A/6A polymorphism with smoking on the onset of young acute myocardial infarction[J].Thromb Haemost,2003,90(1):132-139.
9[9]Yamada Y,Izawa H,Ichihara S,et al.Prediction of the risk of myocardial infarction from polymorphism in candidate genes[J].N Engl J Med,2002,347(24):1916-1923.
10[10]Kim JS,Park HY,Kwon JH,et al.The role of stromelysin-1 and the gelatinase B gene polymorphism in stable angina[J].Yonsei Medical J,2002,43(4):473-481.
